Infinity Total Debt

INFI -  USA Stock  

USD 2.08  0.22  11.83%

Infinity Pharmaceuti fundamentals help investors to digest information that contributes to Infinity Pharmaceuti's financial success or failures. It also enables traders to predict the movement of Infinity Stock. This fundamental analysis module provides a way for investors to measures Infinity Pharmaceuti's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Infinity Pharmaceuti stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Infinity Total Debt 

The current Total Debt is estimated to increase to about 1.5 M.

Infinity Total Debt Analysis

Infinity Pharmaceuti's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Infinity Pharmaceuti Total Debt

1.47 MillionShare
Total Debt 
More About Total Debt | All Equity Analysis

Current Infinity Pharmaceuti Total Debt

  1.6 M  
Most of Infinity Pharmaceuti's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Infinity Pharmaceuti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Infinity Total Debt Driver Correlations

Understanding the fundamental principles of building solid financial models for Infinity Pharmaceuti is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Total Debt. Since Infinity Pharmaceuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Infinity Pharmaceuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Infinity Pharmaceuti's interrelated accounts and indicators.

Infinity Total Debt Historical Pattern

Today, most investors in Infinity Pharmaceuti Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Infinity Pharmaceuti's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Infinity Pharmaceuti total debt as a starting point in their analysis.
 Infinity Pharmaceuti Total Debt 
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Compare to competition

Based on the latest financial disclosure, Infinity Pharmaceuti has a Total Debt of 1.6 M. This is 99.94% lower than that of the Healthcare sector and 99.51% lower than that of the Biotechnology industry. The total debt for all United States stocks is 99.97% higher than that of the company.

Infinity Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Infinity Pharmaceuti's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Infinity Pharmaceuti could also be used in its relative valuation, which is a method of valuing Infinity Pharmaceuti by comparing valuation metrics of similar companies.
Infinity Pharmaceuti is currently under evaluation in total debt category among related companies.

Infinity Pharmaceuti Current Valuation Drivers

We derive many important indicators used in calculating different scores of Infinity Pharmaceuti from analyzing Infinity Pharmaceuti's financial statements. These drivers represent accounts that assess Infinity Pharmaceuti's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Infinity Pharmaceuti's important valuation drivers and their relationship over time.
201620172018201920202021 (projected)
Net Income Per Employee(1.31 M)(1.9 M)(450.12 K)(1.88 M)(1.76 M)(1.89 M)
Revenue Per Employee811.82 K272.73 K885.84 K121.96 K74.53 K76.5 K
Average Assets176.34 M79.52 M56.84 M62.83 M48.01 M49.27 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(25.46 M)(39.83 M)(10.97 M)(44.33 M)(37.56 M)(40.53 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(25.46 M)(39.83 M)(10.97 M)(44.33 M)(37.56 M)(40.53 M)
Earnings before Tax(30.1 M)(42.55 M)(11.25 M)(47.11 M)(40.49 M)(43.69 M)
Average Equity91.26 M58.45 M50.8 M23.83 M(12.69 M)(13.02 M)
Enterprise Value(12.86 M)75.36 M34.89 M34.8 M119.15 M122.29 M
Free Cash Flow(152.88 M)(36 M)(4.71 M)(43.86 M)(35.78 M)(38.61 M)
Invested Capital46.17 M19.15 M3.88 M18.98 M1.11 M1.14 M
Invested Capital Average52.42 M29 M10.69 M20.72 M13.29 M13.64 M
Market Capitalization67.14 M102.94 M67.1 M54.75 M136.12 M139.7 M
Tangible Asset Value125.66 M59.35 M60.22 M49.01 M39.32 M40.35 M
Working Capital77.8 M46.79 M52.1 M34.88 M24.97 M25.63 M

Infinity Pharmaceuti Institutional Holders

Institutional Holdings refers to the ownership stake in Infinity Pharmaceuti that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Infinity Pharmaceuti's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Infinity Pharmaceuti's value.
Security TypeSharesValue
Bvf IncCommon Shares8.4 M28.7 M
Blackrock IncCommon SharesM20.5 M
Vanguard Group IncCommon Shares5.6 M19 M
Millennium Management LlcCommon SharesM10.1 M
Polar Capital Holdings PlcCommon Shares2.5 M8.6 M
D E Shaw Co IncCommon Shares2.2 M7.6 M
Assenagon Asset Management SaCommon Shares1.8 MM
Susquehanna International Group LlpCall Options544.2 K1.9 M

Infinity Fundamentals

About Infinity Pharmaceuti Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Infinity Pharmaceuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Infinity Pharmaceuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Infinity Pharmaceuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2021
Total Debt1.4 M1.5 M
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Infinity Pharmaceuti without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Anywhere Now


Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Infinity Pharmaceuti Piotroski F Score and Infinity Pharmaceuti Altman Z Score analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.